Harvest Pharmaceutical and Health Equity Securities Investment Fund (abbreviation: Harvest Pharmaceutical and Health Stock C, code 005304) announced its latest net value on March 27, up 4.57%.
Harvest Pharmaceutical and Health Stock C was established on December 4, 2017, and the performance comparison benchmark is the return rate of ×70% of the CSI Medical and Health Index + the return of the Hang Seng Healthcare Index ×10% + the return of the China Bond Composite Wealth Index ×20%. The fund has returned 36.83% since its inception, 6.14% this year, 3.06% over the past month, 4.07% over the past year, and -22.92% over the past three years. In the past year, the fund ranked 2972/3480 in its peer group.
The fund manager is Hao Miao. Hao Miao has managed (or intends to manage) the fund since August 11, 2021, with a return of -45.48% during his tenure.
According to the latest periodic report, the fund's top 10 heavy stocks are as follows:
| stock symbol | ,stock name | ,position ratio | , number of shares held (shares). | Market value of the position (RMB). |
| 000423 | Dong'e Ejiao | 7.56% | 1233974 | 77.3948 million |
| 01801 | Innovent Biologics | 6.84% | 2067000 | 70.057 million |
| 688131 | Haoyuan Pharmaceutical | 6.21% | 1781755 | 63.6087 million |
| 600276 | Hengrui Pharmaceutical | 6.06% | 1351614 | 62.0391 million |
| 688617 | Huitai Medical | 5.92% | 162848 | 60.6332 million |
| 600420 | Sinopharm Modern | 5.07% | 4352800 | 51.9724 million |
| 600079 | Humanwell | Pharmaceutical4.16% | 1822900 | 42,619,40688,050 |
| Aibo | Medical3.62% | 407154 | 37,063,200,300,760 | |
| Mindray Medical | 3.44% | 138229 | 35,248,400 | |
| 600085 | Tong Ren Tang | 3.21% | 808,900 | The 32,833,300 |
Ticker Name
Percentage Change
Inclusion Date
